Greenbrook TMS to Participate at the 13th Annual LD Micro Main Event Conference

Greenbrook TMS to Participate at the 13^th Annual LD Micro Main Event Conference

TORONTO–(BUSINESS WIRE)–
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that Bill Leonard, Chief Executive Officer, will present at the 13^th Annual LD Micro Main Event Conference, on December 15, 2020^{at 9:40 a.m. (Eastern Time).}

Interested parties can register to attend at the following link: https://ve.mysequire.com/

About Greenbrook TMS Inc.

Operating through 125 Company-operated treatment centers, Greenbrook is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 510,000 TMS treatments to over 14,000 patients struggling with depression.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201207005080/en/

Glen Akselrod

Investor Relations

Greenbrook TMS Inc.

Contact Information:

[email protected]

1-855-797-4867

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Mental Health Research Biotechnology Other Health Managed Care Health General Health Other Science Science

MEDIA: